Patents Assigned to Universite de Mons
-
Patent number: 11898143Abstract: Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Methods, uses and further products employing such agents are also described.Type: GrantFiled: January 20, 2021Date of Patent: February 13, 2024Assignee: Universite de MonsInventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
-
Patent number: 11370896Abstract: An ionic nanocomposite comprising a nanomaterial comprising charged groups disposed on at least a portion of a surface of the nanomaterial and a polymer material comprising charged pendant group and/or end functionalized charged groups, where the charged groups of the nanomaterial and the charged pendant groups of the polymer material have opposite charges and the nanomaterial and polymer material are connected by one or more ionic bonds. A nanomaterial can be nanoparticles comprising sulfate groups disposed on at least a portion of the surface of the nanoparticles. The polymer material can be a polymer with pendant imidazolium groups. An ionic nanocomposite can be present as a film (e.g., a thin film). An ionic nanocomposite can be used in devices. A nanocomposite can be used in various coating application.Type: GrantFiled: September 12, 2017Date of Patent: June 28, 2022Assignees: CORNELL UNIVERSITY, UNIVERSITÉ DE MONSInventors: Jérémy Odent, Emmanuel P. Giannelis, Jean-Marie Raquez, Philippe Dubois
-
Publication number: 20220146367Abstract: This invention relates to a resonant frequency vibrational test and a method of subjecting a component to such a resonant frequency vibrational test.Type: ApplicationFiled: March 13, 2020Publication date: May 12, 2022Applicant: Universite De MonsInventors: Lassaad BEN FEKIH, Olivier VERLINDEN, Georges KOUROUSSIS
-
Patent number: 10907157Abstract: Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy, are described. Methods, uses and further products employing such agents are also described.Type: GrantFiled: September 5, 2019Date of Patent: February 2, 2021Assignee: Université de MonsInventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
-
Publication number: 20200399761Abstract: A nickel-boron coating deposited on a substrate which comprises nickel, boron and a material selected from bismuth, tin, tellurium, selenium, indium and gallium.Type: ApplicationFiled: January 25, 2019Publication date: December 24, 2020Applicant: UNIVERSITÉ de MONSInventors: LUIZA BONIN, VÉRONIQUE VITRY, FABIENNE DELAUNOIS
-
Publication number: 20200293574Abstract: The present invention is related to a method for indexing audio files comprising the steps of: i) for each audio file, collecting semantic descriptor of the audio file; ii) for each audio-file, generate perceptual information based upon audio content of the file; iii) based upon said perceptual information, generate perceptual descriptor in the form of string data for each audio-file; iv) for each file, create an index comprising both the semantic data and the perceptual descriptor.Type: ApplicationFiled: March 17, 2017Publication date: September 17, 2020Applicant: Universite de MonsInventors: Gabriel Urbain, Alexis Moinet, Christian Frisson
-
Publication number: 20190345358Abstract: The disclosure relates to omniphobic surface coatings including a solution of fluor-modified polymer and crystalline and/or semi-crystalline polymer and/or inorganic nanoparticles. The disclosure further relates to biphilic substrate surfaces for heat exchangers, including 50-95% of the surface showing a first solid-liquid contact angle and 5 to 50% of the surface showing a second solid-liquid contact angle, wherein the second liquid-solid contact angle is at least 10° higher than first liquid-solid contact angle, and the surface area of second contact angle includes a multitude of discrete surface areas of second contact angle dispersed over the substrate surface.Type: ApplicationFiled: June 20, 2017Publication date: November 14, 2019Applicant: Universite de MonsInventors: Joel De Coninck, Connie Josefina Ocando Cordero, Fabio Villa
-
Publication number: 20190256716Abstract: This disclosure relates to a superhydrophobic coating composition including a solution of crystalline and/or semi-crystalline polymer, for example polypropylene, and of an amorphous hydrophobic matrix polymer in a solvent. The coating is robust, resistant to wear, and may be translucent. The disclosure further relates to an article coated with a superhydrophobic coating composition as previously described and a process for preparing the same.Type: ApplicationFiled: June 20, 2017Publication date: August 22, 2019Applicant: Universite de MonsInventors: Joel De Coninck, Connie Josefina Ocando Cordero
-
Patent number: 10378971Abstract: The present invention is related to a method for determining distributed temperature variation of a few mode optical fiber comprising the steps of:—providing a few mode optical fiber;—enlighting a first end of said few mode optical fiber by means of a coherent light source;—determining the interference pattern of coherent light at a second end of the optical fiber;—selecting one maximum of intensity at the second end of the optical fiber by spatially filtering the enlighting at the first end of the optical fiber;—determining the path length of the trajectory of the selected maximum of intensity;—based upon the determined path length of the trajectory of the selected maximum of intensity, determining the temperature variation of the few mode optical fiber.Type: GrantFiled: July 16, 2015Date of Patent: August 13, 2019Assignees: Université de Mons, Emphase SPRLInventors: Frédéric Musin, Marc Wuilpart, Patrice Megret
-
Patent number: 10022190Abstract: Force transducer (10) include two structural members (11, 12) spaced apart to define a gap (101) and being linked to each other. Optical fibers (13) are to the members and are freely suspended in the gap. The optical fibers are configured to provide a change in a detectable optical property responsive to a change in relative position between the two members in one or more predetermined degrees of freedom. Each of the optical fibers (13) is fixed to both structural members and continuous between the members to link the two structural members to each other. The optical fibers are substantially the only structure forming a link between the two structural members (11, 12), such that the arrangement of the optical fibers defines substantially the stiffness of the link between the two structural members in the one or more predetermined degrees of freedom, which stiffness is mainly, such as for at least 95%, determined by the optical fibers.Type: GrantFiled: April 2, 2013Date of Patent: July 17, 2018Assignees: UNIVERSITE LIBRE DE BRUXELLES, UNIVERSITE DE MONSInventors: Jean-Baptiste Valsamis, Nicolas Cauche, Jacques Deviere, Christophe Caucheteur, Valérie Voisin
-
Patent number: 9988628Abstract: The invention teaches antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy. Further elaborated are methods, uses and further products employing such agents.Type: GrantFiled: February 18, 2016Date of Patent: June 5, 2018Assignee: UNIVERSITE DE MONSInventors: Alexandra Belayew, Frederique Coppee, Celine Vanderplanck, Stephen Donald Wilton, Eugenie Ansseau
-
Patent number: 9689021Abstract: The present invention relates to methods for determining the concentration of a free beta-lactam antibiotic in a biological sample. In particular, the present invention relates to methods for measuring a free beta-lactam antibiotic in a biological sample, comprising the steps of: (a) providing at least one class C beta-lactamase, a functional fragment or variant thereof; (b) providing at least one biological sample; (c) contacting said at least one class C beta-lactamase with said at least one biological sample; and (d) determining the concentration of said free beta-lactam antibiotic in said at least one biological sample.Type: GrantFiled: October 15, 2012Date of Patent: June 27, 2017Assignees: UNIVERSITÉ DE LIÈGE, UNIVERSITÉ CATHOLIQUE DE LOUVAIN, UNIVERSITÉ LIBRE DE BRUXELLES, UNIVERSITÉ DE MONS-HAINAUTInventors: Alain Brans, Bernard Joris, Michael Delmarcelle, Jacqueline Marchand, Paul Tulkens, Catherine Hammaecher, Erik Goormaghtigh, Joel De Coninck
-
Publication number: 20170167801Abstract: A composite material, notably for seasonal storage of energy in a domestic heating system, comprises grains having at least one of the following pairings of hygroscopic salt arranged within a porous material (table) with the hygroscopic metal concentration in the central zone of the grain being at least 0.7 times that in the peripheral zone.Type: ApplicationFiled: June 25, 2015Publication date: June 15, 2017Applicants: Universite de Mons, Universite Libre de BruxellesInventors: Emilie COURBON, Marc FRERE, Nicolas HEYMANS, Pierre D'ANS
-
Patent number: 9651537Abstract: The quality and/or aging of an oil is monitored, notably in-situ, using a resonator sensor, for example a quartz crystal microbalance sensor (QCM). Changes of the frequency response of the sensor may be used to detect or monitor the presence of one or a combination of water, fuel, metallic debris, plastic debris and reaction products from degradation of oil components and/or oil additives (including oxidation products and acids). At least one of the major surfaces of the resonator sensor may include a component capturing surface layer provided with impression sites adapted to retain components of the oil indicative of the oil's quality, aging or contamination and both major surfaces of the sensor are preferably immersed in the oil to be monitored.Type: GrantFiled: July 11, 2013Date of Patent: May 16, 2017Assignee: Université de MonsInventors: Joel De Coninck, Sofiene Marouani
-
Publication number: 20150192558Abstract: The quality and/or aging of an oil is monitored, notably in-situ, using a resonator sensor, for example a quartz crystal microbalance sensor (QCM). Changes of the frequency response of the sensor may be used to detect or monitor the presence of one or a combination of water, fuel, metallic debris, plastic debris and reaction products from degradation of oil components and/or oil additives (including oxidation products and acids). At least one of the major surfaces of the resonator sensor may include a component capturing surface layer provided with impression sites adapted to retain components of the oil indicative of the oil's quality, aging or contamination and both major surfaces of the sensor are preferably immersed in the oil to be monitored.Type: ApplicationFiled: July 11, 2013Publication date: July 9, 2015Applicant: UNIVERSITE DE MONSInventors: Joel De Coninck, Sofiene Marouani
-
Publication number: 20150126703Abstract: A process for the preparation of polyesters or polycarbonates including (i) the provision of cyclic esters or cyclic carbonates, (ii) polymerizing by ring-opening in the presence of a betaine based metal-free catalyst showing formula ?X—R1—Y+(R2)3 wherein X is S, O or Se, Y is N or P, R1 is linear or cyclic alkyl or aryl, and R2 is linear or cyclic alkyl. and under polymerizing conditions in the presence of an alcohol or amine based initiator.Type: ApplicationFiled: November 4, 2014Publication date: May 7, 2015Applicant: Universite de MonsInventors: Philippe Ghilain Dubois, Brieuc Guillerm, Olivier Coulembier
-
Patent number: 8981053Abstract: The present invention provides a synthetic peptide molecule that specifically binds an FXYD2-gamma isoform of pancreatic beta cells, said synthetic peptide molecule has 25 amino acids.Type: GrantFiled: June 22, 2012Date of Patent: March 17, 2015Assignees: Universite de Mons, Université Libre de Bruxelles, Eurogentec SAInventors: Robert Muller, Decio L. Eizirik, Corine Sermeus, Sophie Laurent, Carmen Burtea, Marie-Claire Beckers, Daisy Flamez
-
Patent number: 8862472Abstract: The present invention is related to a method for coding excitation signal of a target speech comprising the steps of: extracting from a set of training normalized residual frames, a set of relevant normalized residual frames, said training residual frames being extracted from a training speech, synchronized on Glottal Closure Instant(GCI), pitch and energy normalized; determining the target excitation signal of the target speech; dividing said target excitation signal into GCI synchronized target frames; determining the local pitch and energy of the GCI synchronized target frames; normalizing the GCI synchronized target frames in both energy and pitch, to obtain target normalized residual frames; determining coefficients of linear combination of said extracted set of relevant normalized residual frames to build synthetic normalized residual frames close to each target normalized residual frames; wherein the coding parameters for each target residual frames comprise the determined coefficients.Type: GrantFiled: March 30, 2010Date of Patent: October 14, 2014Assignees: Universite de Mons, Acapela Group S.A.Inventors: Geoffrey Wilfart, Thomas Drugman, Thierry Dutoit
-
Publication number: 20140243241Abstract: The present invention relates to methods for determining the concentration of a free beta-lactam antibiotic in a biological sample. In particular, the present invention relates to methods for measuring a free beta-lactam antibiotic in a biological sample, comprising the steps of: (a) providing at least one class C beta-lactamase, a functional fragment or variant thereof; (b) providing at least one biological sample; (c) contacting said at least one class C beta-lactamase with said at least one biological sample; and (d) determining the concentration of said free beta-lactam antibiotic in said at least one biological sample.Type: ApplicationFiled: October 15, 2012Publication date: August 28, 2014Applicants: UNIVERSITE DE LIEGE, UNIVERSITE DE MONS, UNIVERSITE LIBRE DE BRUXELLES, UNIVERSITE CATHOLIQUE DE LOUVAINInventors: Alain Brans, Bernard Joris, Michael Delmarcelle, Jacqueline Marchand, Paul Tulkens, Catherine Hammaecher, Erik Goormaghtigh, Joel De Coninck
-
Publication number: 20140206033Abstract: A preferred test system includes a chemical and/or biological sample in a liquid test medium and contains both a liquid and a gas phase that simulates air-water gas exchanges. It operates intermittently, with additions and eliminations of liquids being decoupled in time so that to make sure the medium is well mixed before eliminating any liquid; requirement for expensive fixed flow pumps, or accurate flow meters are eliminated while accurate measurement of fluxes between the chemical and/or biological sample, the liquid and the gas phase are possible by mass balance between added and eliminated liquids.Type: ApplicationFiled: June 27, 2012Publication date: July 24, 2014Applicant: UNIVERSITE DE MONSInventors: Philippe Grosjean, Julien Leblud, Antoine Batigny